Flow cytometry analysis of tumor‐associated macrophages (TAMs) further revealed a substantial increase in M1 macrophages (CD86+F4/80+) in the Cu2O@EG + MW compared to PBS, Cu2O@EG alone, and MW alone. The gene discussed is CD86; the disease is neoplasm.